ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626163 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626163; 2) Community: the network communities that were significantly associated with the response to NSC 626163; 3) Molecule: the relationships between components within communities and NSC 626163; 4) MDR: the compounds that were significantly associated with the NSC 626163.

NSC Compound Enrichment Correlation
NSC 686362 Null 0.0430277102950697 0.31525273
NSC 700583 [1,4,2,3]-Dithiaselenoca[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.0430277102950697 0.3788181
NSC 705534 Faradiol 0.0430277102950697 0.11224284
NSC 708431 Null 0.0430277102950697 0.03587915
NSC 709237 Camptothecin Derivative 0.0430277102950697 -0.13248081
NSC 710464 AFP464 0.0430277102950697 0.085542769
NSC 711661 Null 0.0430277102950697 0.43286258
NSC 717067 Null 0.0430277102950697 0.13080135
NSC 720135 Null 0.0430277102950697 0.167306
NSC 720290 Methyl-7.alpha.,12.alpha.-Diacetoxy-5.beta.-cholan-24-oate-3 -spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.0430277102950697 0.17452858
Total:93  Current:89    [First] [Prev] [Next] [Last]